NON HODGKIN LYMPHOMA (NHL)
Clinical trials for NON HODGKIN LYMPHOMA (NHL) explained in plain language.
Never miss a new study
Get alerted when new NON HODGKIN LYMPHOMA (NHL) trials appear
Sign up with your email to follow new studies for NON HODGKIN LYMPHOMA (NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ready-Made immune cells take on lymphoma and leukemia in first human trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called ALA-101 for people with certain types of blood cancer (non-Hodgkin lymphoma and leukemia). ALA-101 uses specially engineered immune cells from a healthy donor that are designed to find and attack cancer cells. The main goal is t…
Matched conditions: NON HODGKIN LYMPHOMA (NHL)
Phase: PHASE1 • Sponsor: Arovella Therapeutics Ltd • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Can radiation and a common antibiotic boost CAR-T therapy for lymphoma?
Disease control Not yet recruitingThis early-stage trial tests whether giving radiation therapy and the antibiotic vancomycin before CAR-T cell treatment is safe and doable for people with large B-cell lymphoma. The study will enroll 14 adults whose lymphoma has come back or not responded to other treatments. The…
Matched conditions: NON HODGKIN LYMPHOMA (NHL)
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 22, 2026 13:53 UTC